Form D · Biotechnology
Agennix Holdings, LLC
Houston, TX · CIK 0001467896
Offering snapshot reported Jul 8, 2009 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 85 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 23, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2009 | Initial | $0 | No comparison | 85 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-132516
This offering is being made as one of the steps in a reorganization transaction pursuant to a Business Combination Agreement dated February 17, 2009.
Source: Form D, filed Jul 8, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rick Barsky | Director, Executive |
| Atul Varadhachary | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8 Greenway Plaza Suite 910
Houston, TX, 77046
Houston, TX, 77046